Literature DB >> 10439048

Mice defective in the DNA mismatch gene PMS2 are hypersensitive to MNU induced thymic lymphoma and are partially protected by transgenic expression of human MGMT.

X Qin1, L Liu, S L Gerson.   

Abstract

DNA mismatch repair (MMR) stabilizes the cellular genome. Mice defective in the MMR gene PMS2 are susceptible to spontaneous thymic lymphoma and sarcomas. To determine the sensitivity of PMS2 knockout mice to environmental carcinogens and the protective effect of O6-methylguanine DNA methyltransferase (MGMT), heterozygous PMS2 knockout mice and human MGMT (hMGMT) transgenic mice were mated and the PMS2-/- and PMS2+/+ with or without hMGMT offspring were treated at 5 weeks of age with 50 mg/kg N-methyl-N-nitrosourea (MNU). MNU produces carcinogenic O6-methylguanine (O6-meG) adducts, resulting in thymic lymphoma in mice, which can be prevented in normal mice by overexpression of hMGMT. A significantly higher incidence of thymic lymphomas was observed in MNU-treated PMS2-/- mice, compared to wildtype PMS2+/+ mice (100 vs 52%; P < 0.001). The mean latency of lymphomas was also significantly shortened in PMS2-/- mice (81 vs 102 days, P < 0.01). Transgenic expression of hMGMT significantly but incompletely blocked MNU lymphomagenesis in PMS2-/- mice. The incidence of lymphomas in PMS2-/-/hMGMT+ mice was reduced to 80% (P < 0.01) and mean latency increased to 91 days (P < 0.05). Thymic lymphomagenesis was efficiently blocked in PMS2+/+/hMGMT+ mice with rapid repair of O6-meG. Since O6-meG:T mismatches in MMR+ cells may trigger mismatch repair resulting in abortive repair and cell death whereas in the absence of MMR, these mismatches are converted to A:T, we predicted that G to A point mutations in codon 12 of the K-ras gene would occur. In this study, we found G to A point mutations in codon 12 of the K-ras gene in many tumors. Thus, in MMR deficient tissues, methylating agents induce point mutations in cells with a higher rate of cell survival which together are potently carcinogenic in the thymus. These data suggest that PMS2 defective lymphomas may arise by the concerted action of environmental and perhaps endogenous methylation of DNA coupled to genomic instability.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10439048     DOI: 10.1038/sj.onc.1202798

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  10 in total

Review 1.  Syndrome of early onset colon cancers, hematologic malignancies & features of neurofibromatosis in HNPCC families with homozygous mismatch repair gene mutations.

Authors:  Prathap Bandipalliam
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

2.  SMARCAD1-mediated recruitment of the DNA mismatch repair protein MutLα to MutSα on damaged chromatin induces apoptosis in human cells.

Authors:  Yukimasa Takeishi; Ryosuke Fujikane; Mihoko Rikitake; Yuko Obayashi; Mutsuo Sekiguchi; Masumi Hidaka
Journal:  J Biol Chem       Date:  2019-12-16       Impact factor: 5.157

Review 3.  Balancing repair and tolerance of DNA damage caused by alkylating agents.

Authors:  Dragony Fu; Jennifer A Calvo; Leona D Samson
Journal:  Nat Rev Cancer       Date:  2012-01-12       Impact factor: 60.716

4.  In vitro and in vivo modulations of benzo[c]phenanthrene-DNA adducts by DNA mismatch repair system.

Authors:  Jianxin Wu; Bei-Bei Zhu; Jin Yu; Hong Zhu; Lu Qiu; Mark S Kindy; Liya Gu; Albrecht Seidel; Guo-Min Li
Journal:  Nucleic Acids Res       Date:  2003-11-15       Impact factor: 16.971

Review 5.  Exploiting DNA Endonucleases to Advance Mechanisms of DNA Repair.

Authors:  Marlo K Thompson; Robert W Sobol; Aishwarya Prakash
Journal:  Biology (Basel)       Date:  2021-06-14

6.  Functional role of DNA mismatch repair gene PMS2 in prostate cancer cells.

Authors:  Shinichiro Fukuhara; Inik Chang; Yozo Mitsui; Takeshi Chiyomaru; Soichiro Yamamura; Shahana Majid; Sharanjot Saini; Guoren Deng; Ankurpreet Gill; Darryn K Wong; Hiroaki Shiina; Norio Nonomura; Yun-Fai C Lau; Rajvir Dahiya; Yuichiro Tanaka
Journal:  Oncotarget       Date:  2015-06-30

7.  Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden.

Authors:  Zachary R Chalmers; Caitlin F Connelly; David Fabrizio; Laurie Gay; Siraj M Ali; Riley Ennis; Alexa Schrock; Brittany Campbell; Adam Shlien; Juliann Chmielecki; Franklin Huang; Yuting He; James Sun; Uri Tabori; Mark Kennedy; Daniel S Lieber; Steven Roels; Jared White; Geoffrey A Otto; Jeffrey S Ross; Levi Garraway; Vincent A Miller; Phillip J Stephens; Garrett M Frampton
Journal:  Genome Med       Date:  2017-04-19       Impact factor: 11.117

8.  Protection against malignant progression of spontaneously developing liver tumors in transgenic mice expressing O(6)-methylguanine-DNA methyltransferase.

Authors:  X Qin; S Zhang; S Matsukuma; M Zarkovic; S Shimizu; T Ishikawa; Y Nakatsuru
Journal:  Jpn J Cancer Res       Date:  2000-11

9.  DNA repair genes are selectively mutated in diffuse large B cell lymphomas.

Authors:  Noel F C C de Miranda; Roujun Peng; Konstantinos Georgiou; Chenglin Wu; Elin Falk Sörqvist; Mattias Berglund; Longyun Chen; Zhibo Gao; Kristina Lagerstedt; Susana Lisboa; Fredrik Roos; Tom van Wezel; Manuel R Teixeira; Richard Rosenquist; Christer Sundström; Gunilla Enblad; Mats Nilsson; Yixin Zeng; David Kipling; Qiang Pan-Hammarström
Journal:  J Exp Med       Date:  2013-08-19       Impact factor: 14.307

Review 10.  Refractory solitary cervical lymph node metastasis after esophageal squamous cell carcinoma surgery and its successful treatment with immune checkpoint inhibitor: A case report and literature review.

Authors:  Wenjing Song; Helei Wang; Yuanyuan Tian; Shiwei Liu; Xiao Chen; Jiuwei Cui; Yuguang Zhao
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.